(Q50867968)

24 March 2018

title

The effect of CCR2 inhibitor CCX140-B on residual albuminuria in patients with type 2 diabetes and nephropathy: a randomised trial. (English)

1 reference

24 March 2018

0 references

1 reference

Dick de Zeeuw

1

1 reference

24 March 2018

Pirow Bekker

2

1 reference

24 March 2018

Elena Henkel

3

1 reference

24 March 2018

Christopher Hasslacher

4

1 reference

24 March 2018

Ioanna Gouni-Berthold

5

1 reference

24 March 2018

Heidrun Mehling

6

1 reference

24 March 2018

Antonia Potarca

7

1 reference

24 March 2018

Vladimir Tesar

8

1 reference

24 March 2018

Hiddo J Lambers Heerspink

9

1 reference

24 March 2018

Thomas J Schall

10

1 reference

24 March 2018

CCX140-B Diabetic Nephropathy Study Group

11

1 reference

24 March 2018

publication date

7 August 2015

1 reference

24 March 2018

The Lancet: Diabetes & Endocrinology

published in

1 reference

24 March 2018

volume

3

1 reference

24 March 2018

issue

9

1 reference

24 March 2018

page(s)

687-696

1 reference

24 March 2018

Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900261-2

7 January 2021

Proteinuria reduction and progression to renal failure in patients with type 2 diabetes mellitus and overt nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900261-2

7 January 2021

Proteinuria should be used as a surrogate in CKD.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900261-2

7 January 2021

Changes in albuminuria predict mortality and morbidity in patients with vascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900261-2

7 January 2021

The kidney in type 2 diabetes therapy

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900261-2

7 January 2021

Cardiorenal end points in a trial of aliskiren for type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900261-2

7 January 2021

Combined angiotensin inhibition for the treatment of diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900261-2

7 January 2021

Monocyte chemoattractant protein 1 in obesity and insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900261-2

7 January 2021

MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900261-2

7 January 2021

MCP-1/CCL2: a new diagnostic marker and therapeutic target for progressive renal injury in diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900261-2

7 January 2021

Molecular cloning and functional expression of two monocyte chemoattractant protein 1 receptors reveals alternative splicing of the carboxyl-terminal tails

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900261-2

7 January 2021

CCR2 antagonist CCX140-B provides renal and glycemic benefits in diabetic transgenic human CCR2 knockin mice

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900261-2

7 January 2021

Sequential Treatment Assignment with Balancing for Prognostic Factors in the Controlled Clinical Trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900261-2

7 January 2021

Functional interaction between angiotensin II receptor type 1 and chemokine (C-C motif) receptor 2 with implications for chronic kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900261-2

7 January 2021

Blockade of CCL2/CCR2 signalling ameliorates diabetic nephropathy in db/db mice

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900261-2

7 January 2021

An acute fall in estimated glomerular filtration rate during treatment with losartan predicts a slower decrease in long-term renal function

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900261-2

7 January 2021

10.1016/S2213-8587(15)00261-2

Identifiers

DOI

1 reference

24 March 2018

1 reference

24 March 2018